Topiramate

Topiramate

Drug monograph · NCLEX study reference
Trade names	Topamax
Therapeutic class	Anticonvulsant, migraine prophylaxis
Pharmacologic class	Sulfamate (multiple mechanisms)
Onset / peak / duration	Effect over titration.
Half-life / level	Half-life about 21 hours; level not routine.
Routes	PO (oral)
High-alert (ISMP)	No
Black box warning	None
Antidote / reversal	None; supportive care.
Pregnancy / lactation	Teratogenic (oral clefts); avoid when possible.

Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.

Topiramate (brand name Topamax) — Anticonvulsant, migraine prophylaxis; Sulfamate (multiple mechanisms).

Identification

• Therapeutic class: Anticonvulsant, migraine prophylaxis.
• Pharmacologic class: Sulfamate (multiple mechanisms).

Pharmacology

• Mechanism of action: Blocks sodium channels, enhances GABA, and inhibits carbonic anhydrase.
• Onset / peak / duration: Effect over titration.
• Half-life / therapeutic level: Half-life about 21 hours; level not routine.

Clinical use

• Indications: Seizures, migraine prophylaxis, weight management combinations.
• Usual dose, route, frequency: Titrated PO once or twice daily.
• Maximum dose / adjustments: Reduce in renal impairment.

Safety

• Contraindications: Hypersensitivity; caution with glaucoma.
• Black box warning: None.
• Interactions: Oral contraceptives (reduced at higher doses), carbonic anhydrase inhibitors, alcohol, CNS depressants.
• Pregnancy / lactation: Teratogenic (oral clefts); avoid when possible.
• High-alert: No.

Adverse effects

• Common side effects: Paresthesias, cognitive slowing, weight loss, taste changes.
• Serious effects to report: Metabolic acidosis, kidney stones, acute glaucoma, decreased sweating with hyperthermia.
• Antidote / reversal: None; supportive care.

Nursing process

• Assessment before administration: Renal function, bicarbonate, vision history.
• Interventions during therapy: Encourage hydration; monitor bicarbonate.
• Monitor: Bicarbonate, renal function, weight, cognition.
• Evaluation / expected outcome: Seizure or migraine control.

Patient teaching

• Patient teaching: Stay hydrated to prevent stones; report eye pain or vision change; backup contraception.
• Notify provider if: Eye pain, blurred vision, flank pain, confusion.
• Administration tips: With or without food; sprinkle capsule onto soft food without chewing.